NCT07886788

Brief Summary

The goal of this randomized clinical trial is to learn whether consuming grapes during their natural season can help the body adapt to the shorter daylight hours of winter. The study includes men and women aged 30-70 years with either normal weight or overweight or obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). The main questions it aims to answer are:

  • Does seasonal grape consumption change circulating microRNAs, small molecules involved in regulating gene activity?
  • Does grape consumption influence sleep, physical activity, metabolic markers, body composition, muscle function, and gut bacteria during the transition to winter? Within each population group, researchers will compare participants consuming yogurt with freeze-dried grape powder with participants consuming the same yogurt without grape powder. Both groups will receive the same Mediterranean-style dietary guidance. Participants will:
  • Consume two yogurts daily for 3 weeks, either with or without a total daily dose of 16 grams of freeze-dried grape powder, equivalent to approximately 80 grams of fresh grapes.
  • Complete a further 2 weeks of follow-up without the grape intervention.
  • Attend an initial information visit and three assessment visits for blood sampling, stool sample collection, and measurements of body composition and muscle function.
  • Wear a wrist device to monitor sleep and physical activity.
  • Complete questionnaires, dietary records, and a sleep diary.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Sep 2026Nov 2026

Study Start

First participant enrolled

September 28, 2026

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

October 14, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 21, 2026

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 6, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2026

Last Updated

October 21, 2026

Status Verified

September 1, 2026

Enrollment Period

1 month

First QC Date

October 14, 2026

Last Update Submit

October 14, 2026

Conditions

Keywords

Seasonal grape consumptionGrape polyphenolsChrononutritionSeasonal photoperiodCircadian rhythmsMetabolic adaptationCirculating microRNAsEpigeneticsGut microbiotaSleep-wake patterns

Outcome Measures

Primary Outcomes (1)

  • Change in circulating plasma microRNA expression

    Differential expression of circulating microRNAs in plasma, comparing changes from baseline between the grape supplementation and control arms at the end of the intervention and after follow-up.

    Baseline (week 0), end of intervention (week 3), and end of follow-up (week 5).

Secondary Outcomes (37)

  • Change in DNA methylation in promoter regions of selected genes

    Baseline (week 0), end of intervention (week 3), and end of follow-up (week 5).

  • Change in serum metabolomic profile

    Baseline (week 0), end of intervention (week 3), and end of follow-up (week 5).

  • Change in gut microbiota diversity and composition

    Baseline (week 0), end of intervention (week 3), and end of follow-up (week 5).

  • Change in body weight

    Baseline (week 0), end of intervention (week 3), and end of follow-up (week 5).

  • Change in body mass index

    Baseline (week 0), end of intervention (week 3), and end of follow-up (week 5).

  • +32 more secondary outcomes

Study Arms (2)

Experimental: Freeze-Dried Grape Powder with Yogurt

EXPERIMENTAL

Participants consume 16 g of freeze-dried grape powder daily, equivalent to approximately 80 g of fresh grapes, divided between two servings of plain, low-fat yogurt without added sugar, taken in the morning and afternoon for 3 weeks. Participants also receive Mediterranean-style dietary guidance. The intervention is followed by 2 weeks without grape supplementation.

Dietary Supplement: Freeze-Dried Grape PowderOther: Plain Low-Fat YogurtBehavioral: Mediterranean-Style Dietary Guidance

Control: Yogurt Alone

ACTIVE COMPARATOR

Participants consume two servings of plain, low-fat yogurt without added sugar daily, taken in the morning and afternoon for 3 weeks, without freeze-dried grape powder. Participants receive the same Mediterranean-style dietary guidance as the experimental arm. The intervention is followed by a 2-week follow-up period.

Other: Plain Low-Fat YogurtBehavioral: Mediterranean-Style Dietary Guidance

Interventions

Freeze-Dried Grape PowderDIETARY_SUPPLEMENT

Freeze-dried Cabernet Sauvignon grape powder administered orally at a total dose of 16 g/day, equivalent to approximately 80 g of fresh grapes. The daily dose is divided into two servings, mixed with plain, low-fat yogurt without added sugar and consumed in the morning and afternoon for 3 weeks during the local grape harvest season. This is followed by 2 weeks without grape supplementation.

Experimental: Freeze-Dried Grape Powder with Yogurt

Two daily servings of plain, low-fat yogurt without added sugar, consumed in the morning and afternoon for 3 weeks.

Control: Yogurt AloneExperimental: Freeze-Dried Grape Powder with Yogurt

Both arms receive the same dietary guidance based on a Mediterranean dietary pattern.

Control: Yogurt AloneExperimental: Freeze-Dried Grape Powder with Yogurt

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women aged 30-70 years.
  • Body mass index (BMI) between 18.5 and 39.9 kg/m².
  • Written informed consent.
  • Membership in one of the following population groups:
  • Normal-weight group: BMI between 18.5 and 24.9 kg/m².
  • Overweight or obesity group: BMI between 25.0 and 39.9 kg/m² and a diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD).

You may not qualify if:

  • Alcohol consumption exceeding 10 g/day or use of other toxic substances.
  • Acute or chronic liver disease of an etiology other than MASLD.
  • Active inflammatory, infectious, or neoplastic disease.
  • Pregnancy.
  • Women receiving hormonal contraceptive treatment.
  • Antibiotic treatment within the 4 weeks before enrollment.
  • Chronic treatment with corticosteroids and/or nonsteroidal anti-inflammatory drugs (NSAIDs).
  • Milk protein allergy.
  • Grape-related food intolerances.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitari Joan XXIII - Unitat d'Investigació Clínica, IRB CatSud

Tarragona, Tarragona, 43005, Spain

Location

Related Publications (13)

  • Escobar-Martinez I, Arreaza-Gil V, Arola-Arnal A, Muguerza B, Mulero M, Suarez M, Torres-Fuentes C. Circannual Rhythms Affect the Bioavailability of Phenolic Compounds from Grape Seed Proanthocyanidins Extract Differently in Healthy and Obese Fischer 344 Rats. J Agric Food Chem. 2025 Oct 8;73(40):25329-25339. doi: 10.1021/acs.jafc.5c03952. Epub 2025 Sep 26.

    PMID: 41002217BACKGROUND
  • Ribas-Latre A, Baselga-Escudero L, Casanova E, Arola-Arnal A, Salvado MJ, Blade C, Arola L. Dietary proanthocyanidins modulate BMAL1 acetylation, Nampt expression and NAD levels in rat liver. Sci Rep. 2015 Jun 8;5:10954. doi: 10.1038/srep10954.

    PMID: 26051626BACKGROUND
  • Soliz-Rueda JR, Lopez-Fernandez-Sobrino R, Torres-Fuentes C, Bravo FI, Suarez M, Mulero M, Muguerza B. Metabolism disturbance by light/dark cycle switching depends on the rat health status: the role of grape seed flavanols. Food Funct. 2023 Jul 17;14(14):6443-6454. doi: 10.1039/d3fo00260h.

    PMID: 37377055BACKGROUND
  • Arreaza-Gil V, Palacios-Jordan H, Romero MDM, Torres-Fuentes C, Rodriguez MA, Remesar X, Fernandez-Lopez JA, Arola-Arnal A. Administration time effect of dietary proanthocyanidins on the metabolome of Fischer 344 rats is sex- and diet-dependent. Food Funct. 2023 Jul 31;14(15):6941-6956. doi: 10.1039/d3fo01551c.

    PMID: 37432474BACKGROUND
  • Ribas-Latre A, Baselga-Escudero L, Casanova E, Arola-Arnal A, Salvado MJ, Arola L, Blade C. Chronic consumption of dietary proanthocyanidins modulates peripheral clocks in healthy and obese rats. J Nutr Biochem. 2015 Feb;26(2):112-9. doi: 10.1016/j.jnutbio.2014.09.006. Epub 2014 Oct 13.

    PMID: 25459887BACKGROUND
  • Ribas-Latre A, Del Bas JM, Baselga-Escudero L, Casanova E, Arola-Arnal A, Salvado MJ, Arola L, Blade C. Dietary proanthocyanidins modulate melatonin levels in plasma and the expression pattern of clock genes in the hypothalamus of rats. Mol Nutr Food Res. 2015 May;59(5):865-78. doi: 10.1002/mnfr.201400571. Epub 2015 Mar 23.

    PMID: 25677201BACKGROUND
  • Rodriguez RM, Colom-Pellicer M, Hernandez-Baixauli J, Calvo E, Suarez M, Arola-Arnal A, Torres-Fuentes C, Aragones G, Mulero M. Grape Seed Proanthocyanidin Extract Attenuates Cafeteria-Diet-Induced Liver Metabolic Disturbances in Rats: Influence of Photoperiod. Int J Mol Sci. 2024 Jul 14;25(14):7713. doi: 10.3390/ijms25147713.

    PMID: 39062955BACKGROUND
  • Arreaza-Gil V, Escobar-Martinez I, Suarez M, Bravo FI, Muguerza B, Arola-Arnal A, Torres-Fuentes C. Gut Seasons: Photoperiod Effects on Fecal Microbiota in Healthy and Cafeteria-Induced Obese Fisher 344 Rats. Nutrients. 2022 Feb 8;14(3):722. doi: 10.3390/nu14030722.

    PMID: 35277081BACKGROUND
  • Arola-Arnal A, Cruz-Carrion A, Torres-Fuentes C, Avila-Roman J, Aragones G, Mulero M, Bravo FI, Muguerza B, Arola L, Suarez M. Chrononutrition and Polyphenols: Roles and Diseases. Nutrients. 2019 Oct 30;11(11):2602. doi: 10.3390/nu11112602.

    PMID: 31671606BACKGROUND
  • Ibars M, Aragones G, Ardid-Ruiz A, Gibert-Ramos A, Arola-Arnal A, Suarez M, Blade C. Seasonal consumption of polyphenol-rich fruits affects the hypothalamic leptin signaling system in a photoperiod-dependent mode. Sci Rep. 2018 Sep 11;8(1):13572. doi: 10.1038/s41598-018-31855-y.

    PMID: 30206280BACKGROUND
  • Iglesias-Carres L, Mas-Capdevila A, Bravo FI, Arola L, Muguerza B, Arola-Arnal A. Exposure of Fischer 344 rats to distinct photoperiods influences the bioavailability of red grape polyphenols. J Photochem Photobiol B. 2019 Oct;199:111623. doi: 10.1016/j.jphotobiol.2019.111623. Epub 2019 Sep 10.

    PMID: 31525717BACKGROUND
  • Manocchio F, Soliz-Rueda JR, Ribas-Latre A, Bravo FI, Arola-Arnal A, Suarez M, Muguerza B. Grape Seed Proanthocyanidins Modulate the Hepatic Molecular Clock via MicroRNAs. Mol Nutr Food Res. 2022 Dec;66(23):e2200443. doi: 10.1002/mnfr.202200443. Epub 2022 Oct 26.

    PMID: 36189890BACKGROUND
  • Soliz-Rueda JR, Lopez-Fernandez-Sobrino R, Bravo FI, Aragones G, Suarez M, Muguerza B. Grape Seed Proanthocyanidins Mitigate the Disturbances Caused by an Abrupt Photoperiod Change in Healthy and Obese Rats. Nutrients. 2022 Apr 27;14(9):1834. doi: 10.3390/nu14091834.

    PMID: 35565801BACKGROUND

Related Links

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Randomized, parallel-group nutritional intervention study with two population cohorts: adults with normal weight and adults with overweight or obesity and MASLD.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student

Study Record Dates

First Submitted

October 14, 2026

First Posted

October 21, 2026

Study Start

September 28, 2026

Primary Completion (Estimated)

November 6, 2026

Study Completion (Estimated)

November 6, 2026

Last Updated

October 21, 2026

Record last verified: 2026-09

Locations